Business Context and Reporting Period
Company: Daré Bioscience, Inc. (DARE)
Filing Type: Form 8-K (Current Report)
Date of Report: January 6, 2026
Event: Regulation FD Disclosure regarding the release of an updated corporate presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of a corporate presentation and does not contain audited or unaudited financial statements.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The only reported event is the dissemination of an updated corporate presentation to investors.
Guidance, Outlook, and Risks
Management Commentary: The Company made an updated corporate presentation available on its investor website. A copy is included as Exhibit 99.1.
Legal Disclaimer: The information in Item 7.01 and Exhibit 99.1 is furnished, not "filed," under the Exchange Act. It is not subject to Section 18 liabilities and is not incorporated by reference into other filings unless expressly stated.
Risks: The filing explicitly states that information contained in or accessible through the Company's website is not incorporated by reference into this report.
Key Facts for Investor Verification
- Verify the content of the corporate presentation dated January 6, 2026, available as Exhibit 99.1 on the Company's investor relations website.
- Confirm that the presentation is not legally "filed" with the SEC and carries different liability standards than formal financial reports.
- Note that no financial data is contained within this specific 8-K document; investors must refer to the attached presentation or prior 10-K/10-Q filings for financial metrics.